Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13-68
SponsorUniversity of Pennsylvania
About this trial
Primary graft dysfunction (PGD) is a severe lung complication that can occur in the days after lung transplant surgery. This study will analyze blood samples to determine if high levels of certain chemicals may increase the risk of developing PGD after a lung transplant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing lung or combined heart and lung transplantation
Disqualifiers
Undergoing combined organ transplantation other than heart and lung transplantation
Trial population
People undergoing lung transplantation
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Primary graft dysfunction, defined by the ISHLT criteria
Time frame
Measured within 72 hours following transplantationSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Pennsylvania
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Columbia University
Collaborator
University of Alabama at Birmingham
Collaborator
Vanderbilt University
Collaborator
Stanford University
Collaborator
Johns Hopkins University
Collaborator
University of Michigan
Collaborator
Duke University
Collaborator
University of Pittsburgh
Collaborator
University of Chicago
Collaborator
Source ClinicalTrials.gov